← Back to all earnings calls

BridgeBio Pharma, Inc. Q2 FY2023 Earnings Call

BridgeBio Pharma, Inc. (BBIO)

Earnings Call FY2023 Q2 Call date: 2023-08-28 Concluded

Share

Quarter scorecard

Revenue

$1.64M

-97.8% YoY

Diluted EPS

$-0.98

Net income

-$160.70M

Documents & deck